SOCS-3 is Involved in the Downregulation of the Acute Insulin-Like Effects of Growth Hormone in Rat Adipocytes by Inhibition of Jak2/IRS-1 Signaling

M. Ridderstråle; J. Amstrup; D. J. Hilton; N. Billestrup; H. Tornqvist

doi:10.1055/s-2003-39077

Hormone and Metabolic Research, Inhaltsverzeichnis

Horm Metab Res 2003; 35(3): 169-177
DOI: 10.1055/s-2003-39077

Original Basic

SOCS-3 is Involved in the Downregulation of the Acute Insulin-Like Effects of Growth Hormone in Rat Adipocytes by Inhibition of Jak2/IRS-1 Signaling

M. Ridderstråle ¹ , J. Amstrup ² , D. J. Hilton ³ , N. Billestrup ^2, ⁴ , H. Tornqvist ^1, ^2, ⁵

¹ Department of Endocrinology, Lund University, Wallenberg Laboratory, University Hospital Malmö, Malmö, Sweden
² Hagedorn Research Institute, Gentofte, Denmark
³ The Walter and Eliza Hall Institute, Victoria, Australia
⁴ Present address: Steno Hospital, Niels Steensens Vej 2, 2820 Gentofte, Denmark
⁵ Present address: Diabetes Biology, Novo Allé, Novo Nordisk A/S, 2880 Bagsværd, Denmark

Abstract

One of the long-term effects of growth hormone (GH) in adipocytes is to maintain a state of refractoriness to insulin-like effects, a refractoriness which otherwise declines within a few hours of GH starvation. Here, we examined differences in GH signaling and the possible role for the recently identified family of suppressors of cytokine signaling (SOCS) proteins in the transition between the refractory and the responsive states in rat adipocytes. The ability of GH to stimulate lipogenesis and tyrosine phosphorylation of the GH receptor (GHR), Janus kinase 2 (Jak2), insulin receptor substrate-1 (IRS-1) and -2 (IRS-2) was greatly reduced in refractory as compared to responsive primary rat adipocytes. However, phosphorylation of Signal Transducer and Activator of Transcription 5 (Stat5) was not affected. SOCS-3 and CIS mRNA levels were significantly higher in refractory compared to responsive cells and could be induced by GH, whereas the level of SOCS-2 mRNA was unchanged. With overexpression of GHR, Jak2 and IRS-1 along with each of these SOCS proteins in human A293 cells, we could demonstrate that both SOCS-1 and SOCS-3 completely inhibited the GH-stimulated tyrosine phosphorylation of IRS-1, whereas SOCS-2 and CIS did not. Our data suggest that GH induces refractoriness to the insulin-like effects in a negative-feedback manner by inhibiting GH-induced GHR/Jak2/IRS-1/IRS-2 phosphorylation through upregulation of SOCS-3, which almost completely blocks Jak2 activation.

Key words

Phosphorylation - Lipogenesis - STAT 5 - Transient Expression - A293 Cells

Volltext

Referenzen

References

1 Isaksson O GP, Edén S, Jansson J O. Mode of action of pituitary growth hormone on target cells. Ann Rev Physiol. 1985; 47 483-499
2 Press M. Growth hormone and metabolism. Diabetes Metab Rev. 1988; 4 391-414
3 Davidson M. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev. 1987; 8 115-131
4 Wabitsch M, Hauner H, Heinze E, Teller W. In vitro effects of growth hormone in adipose tissue. Acta Paediatr Suppl. 1994; 83 48-53
5 Wabitsch M, Heinze E, Hauner H, Shymko R M, Teller W M, de Meyts P. Ilondo M. Biological effects of human growth hormone in rat adipocyte precursor and newly differentiated adipocytes in primary culture. Metabolism. 1996; 45 34-42
6 Edén S, Schwartz J, Kostyo J L. Effects of preincubation on the ability of rat adipocytes to bind and response to growth hormone. Endocrinology. 1982; 111 1505-1512
7 Eriksson H, Ridderstråle M, Tornqvist H. Tyrosin phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like effects of GH in primary rat adipocytes. Endocrinology. 1995; 136 5093-5101
8 Ridderstråle M, Degerman E, Tornqvist H. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes. J Biol Chem. 1995; 270 3471-3474
9 Souza S C, Frick G P, Yip R, Lobo R B, Tai L R, Goodman H M. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1. J Biol Chem. 1994; 269 30 085-30 088
10 Ridderstråle M, Tornqvist H. PI-3-kinase inhibitor wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes. Biochem Biophys Res Commun. 1994; 203 306-310
11 Fain J N. Studies on the role of RNA and protein synthesis in the lipolytic action of growth hormone in isolated fat cells. Adv Enzyme Regul. 1967; 5 39-51
12 Fain J N, Saperstein R. The involvement of RNA synthesis and cyclic AMP in the activation of fat cell lipolysis by growth hormone and glucocorticoids. Horm Metab Res. 1970; 2 20-27
13 Campbell G S, Pang L, Miyasaka T, Saltiel A R, Carter-Su C. Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts. J Biol Chem. 1992; 267 6074-6080
14 Winston L A, Bertics P J. Growth hormone stimulates the tyrosine phosphorylation of 42- and 45-kDa ERK-related proteins. J Biol Chem. 1992; 267 4747-4751
15 Anderson N G. Growth hormone activates mitogen-activated protein kinase and S6 kinase and promotes intracellular tyrosine phosphorylation in 3T3-F442A preadipocytes. Biochem J. 1992; 284 649-652
16 Schindler C, Darnell J E. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem. 1995; 64 621-651
17 Carter-Su C, Schwartz J, Smit L S. Molecular mechanism of growth hormone action. Ann Rev Physiol. 1996; 58 187-207
18 Ridderstråle M, Groop L. Differential phosphorylation of Janus kinase 2, Stat5A and Stat5B in response to growth hormone in primary rat adipocytes. Mol Cell Endocrinol. 2001; 183 49-54
19 Goodman H M. Separation of early and late responses of adipose tissue to growth hormone. Endocrinology. 1981; 109 120-129
20 Schwartz Y, Yamaguchi H, Goodman H M. Growth hormone increases intracellular free calcium in rat adipocytes: correlation with actions on carbohydrate metabolism. Endocrinology. 1992; 131 772-778
21 Starr R, Willson T A, Viney E M, Murray L J, Rayner J R, Jenkins B J, Gonda T J, Alexander W S, Metcalf D, Nicola N A, Hilton D J. A family of cytokine-inducible inhibitors of signalling. Nature. 1997; 387 917-921
22 Endo T A, Masuhara M, Tokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 1997; 387 921-924
23 Auernhammer C J, Melmed S. The central role of OSCS-3 in integrating the neuro-immunoendocrine interface. J Clin Invest. 2001; 108 1735-1740
24 Adams T E, Hansen J A, Starr R, Nicola N A, Hilton D J, Billestrup N. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J Biol Chem. 1998; 273 1285-1287
25 Favre H, Benhamou A, Finidori J, Kelly P A, Edery M. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. FEBS Lett. 1999; 453 63-66
26 Ram P A, Waxman D J. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by mutiple mechanisms. J Biol Chem. 1999; 274 35 553-35 561
27 Rodbell M. Metabolism of isolated fat cells. J Biol Chem. 1964; 239 375-380
28 Moody A J, Stan M A, Stan M, Glieman J. A simple free fat cell bioassay for insulin. Horm Metab Res. 1974; 6 12-16
29 Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol. 1987; 7 2745-2752
30 Gorman C M, Gies D, McCray G, Huang M. The human cytomegalovirus major immediate early promoter can be trans-activated by adenovirus early proteins. Virology. 1989; 171 377-385
31 Jensen J, Serup P, Karlsen C, Nielsen T F, Madsen O D. mRNA profiling of rat islet tumors reveals nkx 6.1 as a beta-cell-specific homeodomain transcription factor. J Biol Chem. 1996; 271 18 749-18 758
32 Ridderstråle M, Tornqvist H. Effects of tyrosine kinase inhibitors on tyrosine phosphorylations and the insulin-like effects in response to human growth hormone in isolated rat adipocytes. Endocrinology. 1996; 137 4650-4656
33 Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 1994; 372 182-186
34 Araki E, Lipes M A, Patti M E, Bruning J C, Haag B, Johnson R S, Kahn C R. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature. 1994; 372 186-190
35 Sun X J, Wang L M, Zhang Y T, Yenush L, Myers M G, Glasheen E, Lane W S, Pierce J H, White M F. Role of IRS-2 in insulin and cytokine signalling. Nature. 1995; 377 173-177
36 Lavan B E, Lane W S, Lienhard G E. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem. 1997; 272 11 439-11 443
37 Argetsinger L S, Norstedt G, Billestrup N, White M F, Carter-Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J Biol Chem. 1996; 271 29 415-29 421
38 Chow J C, Ling P R, Qu Z, Laviola L, Ciccarone A, Bistrian B R, Smith R J. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Endocrinology. 1996; 137 2880-2886
39 Yamauchi T, Kaburagi Y, Ueki K, Tsuji Y, Stark G R, Kerr I M, Tsushima T, Akanuma Y, Komuro I, Tobe K, Yazaki Y, Kadowaki T. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase. J Biol Chem. 1998; 273 15 719-15 726
40 Thirone A C, Carvalho C R, Saad M J. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues. Endocrinology. 1999; 140 55-62
41 Villanueva-Peñacarrillo M L, Márquez L, González N, Díaz-Miguel M, Valverde I. Effect of GLP-1 on lipid metabolism in human adipocytes. Horm Metab Res. 2001; 33 73-77
42 Lobie P E, Mertani H, Morel G, Moralesbustos O, Norstedt G, Waters M J. Receptor-mediated nuclear translocation of growth hormone. J Biol Chem. 1994; 269 21 330-21 339
43 Lobie P E, Wood T JJ, Chen C M, Waters M J, Norstedt G. Nuclear translocation and anchorage of the growth hormone receptor. J Biol Chem. 1994; 269 31 735-31 746
44 Argetsinger L S, Campbell G S, Yang X, Witthuhn B A, Silvennoinen O, Ihle J N, Carter-Su C. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell. 1993; 74 237-244
45 Johnston J A, Kawamura M, Kirken R A, Chen Y, Blake T B, Shibuya K, Ortaldo J R, Mcvicar D W, O'Shea J J. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature. 1994; 370 151-153
46 Smit L S, Meyer D J, Billestrup N, Norstedt G, Schwartz J, Carter-Su C. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3 and 5 by GH. Mol Endocrinol. 1996; 10 519-533
47 Han Y L, Leaman D W, Watling D, Rogers N C, Groner B, Kerr I M, Wood W I, Stark G R. Participation of JAK and STAT proteins in growth hormone-induced signaling. J Biol Chem. 1996; 271 5947-5952
48 Carter-Su C, Smit L S. Signaling via JAK tyrosine kinases: growth hormone receptor as a model system. Recent Prog Horm Res. 1998; 53 61-82
49 Zhu T, Goh E L, Lobie P E. Growth hormone stimulates the tyrosine phosphorylation and association of p125 focal adhesion kinase (FAK) with JAK2. Fak is not required for Stat-mediated transcription. J Biol Chem. 1998; 273 10 682-10 689
50 Zhu T, Goh E LK, LeRoith D, Lobie P E. Growth hormone stimulates the formation of a multiprotein signaling complex involving p130(Cas) and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK). J Biol Chem. 1998; 273 33 864-33 875
51 Silva C M, Lu H, Day R N. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. Mol Endocrinol. 1996; 10 508-518
52 Ilondo M M, Damholt A B, Cunningham B A, Wells J A, Demeyts P, Shymko R M. Receptor dimerization determines the effects of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes. Endocrinology. 1994; 134 2397-2403
53 Bousquet C, Susini C, Melmed S. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. J Clin Invest. 1999; 104 1277-1285
54 Bjorbaeck C, El-Haschimi K, Frantz J D, Flier J S. The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem. 1999; 274 30 059-30 065
55 Pezet A, Favre H, Kelly P A, Edery M. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling. J Biol Chem. 1999; 274 24 497-24 502
56 Siewert E, Muller-Esterl W, Starr R, Heinrich P C, Schaper F. Different protein turnover of interleukin-6-type cytokine signalling components. Eur J Biochem. 1999; 265 251-257
57 Sotiropoulos A, Perrotapplanat M, Dinerstein H, Pallier A, Postelvinay M C, Finidori J, Kelly P A. Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription. Endocrinology. 1994; 135 1292-1298
58 Vanderkuur J A, Wang X Y, Zhang L Y, Campbell G S, Allevato G, Billestrup N, Norstedt G, Carter-Su C. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase. J Biol Chem. 1994; 269 21 709-21 717
59 Frank S J, Gilliland G, Kraft A S, Arnold C S. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology. 1994; 135 2228-2239
60 Yip R G, Goodman H M. Growth hormone and dexamethasone stimulate lipolysis and activate adenylyl cyclase in rat adipocytes by selectively shifting Gi alpha2 to lower density membrane fractions. Endocrinology. 1999; 140 1219-1227

Dr. M. Ridderstråle

Dept of Endocrinology · Wallenberg Laboratory · University Hospital Malmö

20502 Malmö · Sweden

Telefon: + 46 (40) 337215

Fax: + 46 (40) 337042

eMail: martin.ridderstrale@endo.mas.lu.se